Global Equities Face Geopolitical Headwinds
Finance

Global Equities Face Geopolitical Headwinds

authorBy David Rubenstein
DateMay 28, 2026
Read time2 min
This article provides an analysis of the performance of international equity markets, particularly in light of escalating geopolitical tensions between the U.S., Israel, and Iran. It delves into the market's response, key portfolio adjustments made by Franklin Templeton, and the broader economic implications, especially for Europe, concerning inflation, interest rates, and consumer demand.

Navigating Global Volatility: A Strategic Outlook for International Equities

International Markets React to Geopolitical Tensions

In March, global stock markets saw a decline as the conflict between the U.S.-Israel alliance and Iran intensified. This escalation resulted in a mixed performance across the quarter for international equities. Despite a 1.2% decrease, the MSCI EAFE Index managed to surpass the S&P 500 Index, which indicates a degree of resilience in non-U.S. developed markets. Value-oriented stocks continued to lead the market, a trend often observed during periods of increased uncertainty and inflation.

Strategic Portfolio Adjustments Amidst Market Shifts

In response to the evolving market landscape, our portfolio has undergone significant adjustments. We have notably reduced our exposure to software companies, including a substantial cut of approximately two-thirds in our holdings of Germany's SAP. These strategic shifts aim to mitigate risks associated with the current economic climate and position the portfolio for stability.

Economic Repercussions for Europe and Beyond

The geopolitical conflicts are profoundly impacting global cost structures, particularly affecting energy-reliant European economies. This situation introduces increased uncertainty surrounding key economic indicators such as inflation, interest rates, and consumer spending. The interconnectedness of global markets means that regional conflicts have far-reaching consequences, necessitating a cautious and adaptive investment approach.

More Articles
Finance
Columbia High Yield Municipal Fund Q1 2026 Performance Review
In Q1 2026, the Columbia High Yield Municipal Fund's Institutional Class shares yielded a 0.37% return, falling short of its benchmark, the High Yield Municipal Blended Index, which saw a 0.54% return. The underperformance was primarily attributed to strategic positioning in duration and curve, specifically an overweighting in long-dated bonds. However, strong security selection partially mitigated these factors. The fund continues to focus on credits and structures that appropriately compensate for both interest-rate and credit risks, targeting intermediate-to-long maturities.
By Michele FerreroMay 28, 2026
Finance
Top Debt Payoff Planners for Optimal Financial Management
This article reviews the best debt payoff planners available in June 2026, based on Investopedia's comprehensive research. It highlights top choices like "Debt Payoff Planner" for its simplicity and affordability, "You Need a Budget (YNAB)" for its detailed budgeting approach, "Unbury.me" for a straightforward web-based solution, and "Vertex42 Debt Reduction Calculator" for spreadsheet enthusiasts. Additionally, "Undebt.it" is featured for its robust integration capabilities. Each planner is evaluated on cost, debt strategies, platforms, and unique features to help individuals effectively manage and reduce their debt.
By Robert KiyosakiMay 28, 2026
Finance
Baron Capital Initiates Position in Essential Properties Realty Trust, Highlighting Growth Potential
Baron Capital has acquired shares in Essential Properties Realty Trust, a triple net lease REIT with a portfolio of approximately 2,300 diverse properties across the U.S. The company boasts a diversified tenant base, with no single tenant exceeding 2% of annualized rent. With a 4% dividend yield and robust high-single-digit earnings growth, EPRT is positioned for attractive double-digit annual returns for investors.
By Strive MasiyiwaMay 28, 2026
Finance
A Contrarian View: Why Novo Nordisk May Outperform Eli Lilly
This analysis presents a contrarian perspective on the pharmaceutical market's current leaders in GLP-1 weight loss drugs, Eli Lilly and Novo Nordisk. While Eli Lilly currently dominates with its highly successful Mounjaro and Zepbound, Novo Nordisk's recent release of a pill-form Wegovy and its attractive valuation and dividend yield make it a compelling investment, especially for value and dividend-focused investors, despite its slower growth in the obesity care segment.
By Nouriel RoubiniMay 28, 2026
Finance
US New Home Sales Market Cap Sees Significant Decline in April 2026
The U.S. new home market experienced a downturn in April 2026, with total sales valuation falling below previous month's levels. This decline is attributed to a combination of rising mortgage rates and increased average sale prices, which collectively reduced the quantity of new homes sold. Despite a recovery from January's blizzards, the market faces renewed challenges.
By Lisa JingMay 28, 2026